logo
International Conference and Exhibition on
Biowaivers and Biosimilars
September 10-12, 2012 Hilton San Antonio Airport, USA
Biosimilars-2012

    Previous Events
     
     
    OMICS Group Conferences: Membership


    One of the central values of OMICS Group as an organizer of over 50 conferences a year is that, membership for the conferences is free to all of those who wish to participate. Our conferences will reflect an inter-proficient and International outlook across all phases of scientific community.


    The most important function of OMICS Group Conferences is to provide a forum for presenting cutting-edge research ideas and exchange of Knowledge. In addition, our conferences offer attendees the prospect of identifying new research directions or approaches, networking with colleagues, developing collaborations, and advancing their careers. There are personal benefits that can still be derived from scientific meetings, apart from sharing knowledge developing network and collaborations. The personal gains, of course, multiply through the privilege of Memberships. So, by all means, Individuals and organizations in research, industry, government, community groups, consultancies or educational institutions -- those who want to get more benefited can therefore subscribe for free Membership

     
    Benefits
    Free Membership
    Cost effective
    Increased Exposure
    Professional Rewards Program (PRP)

    OMICS Group Symposia:Membership offers you an exclusive benefit of organizing your university /Institute/Society/ corporate Symposia in any of the OMICS Group Conferences at reduced price tariffs. For more details contact organizers at symposia@omicsonline.com


    Click here to download OMICS Group Brochure
    Click here to Download OMICS Group Conference Membership form
    Final Program
    Final  Program
    Renowned Speakers
    speker Carmine Lanni
    Bioanalytical Development Services, USA

    speker Veysel Kayser
    MIT, USA

    speker Paul A. Calvo
    Sterne, Kessler, Goldstein & Fox, USA

    speker Brian R. Dorn
    Barnes & Thornburg LLP, USA

    speker Ben Kaspar
    MMS Holdings Inc., USA

    speker William Velander
    University of Nebraska, USA

    speker Parastoo Azadi
    University of Georgia, USA

    speker Bryan J. Vogel
    Robins, Kaplan, Miller & Ciresi L.L.P, USA

    speker Laszlo Endrenyi
    University of Toronto, Canada

    speker Leandro Mieravilla
    Biosimilar-Boitech Global Expert, Canada

    speker Michael D. McLean
    PlantForm Corporation, Canada

    speker David Goodall
    Paraytec Limited, UK

    speker Joachim Stellmach
    European Patent Office, Germany

    speker Faud Fares
    University of Haifa, Israel

    speker Lisa J. Murray
    Absorption Systems, USA

    speker Kelly S. Colletti
    Charles River Preclinical Services, USA

    speker Indu Javeri
    CuriRx Inc, USA

    speker Amal Ali Elkordy
    University of Sunderland, UK

    speker Melody Sauerborn
    ADA-In Vivo, Netherlands

    speker Gustavo Helguera
    University of Buenos Aires, Argentina

    speker Su Chen
    Chainon Neurotrophin Biotechnology Inc, USA

    speker Hong Zhao
    Enzon Pharmaceuticals, USA

    speker Xing Wang
    Array Bridge Inc, USA

    speker Ming Wang
    Gan & Lee Pharmaceuticals, China

    Popular Journals
    Media Partner
    images
     
     
    follow
    Conference Secretariat: Biosimilars-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Tel: +1-650-268-9744 | Fax: +1-650-618-1414
    Toll free: 1-800-216-6499 (USA & Canada), 1-800-651-097 (Australia), 0805-080048 (Europe)
    Email: biosimilars2012@omicsgroup.com
    Operated by: Editors- Journal of Bioanalysis and Biomedicine, Journal of Bioequivalence and Bioavailability, Pharmaceutica Analytica Acta
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version